1.42000 USD
0.03
2.07%
Last update Dec 15, 3:59 PM EST
Market closed
Day range
1.40500
1.48000
Previous close
1.45000
Open
1.47000
Access this stock data via API
Subscribe
Telomir Pharmaceuticals Inc.
1.42
0.03
2.07%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 2.2M 1.6M 833.2K 126.5K
Selling general and admin 9.6M 600.2K 20.9K 11.6K
Other operating expenses 370.5K 1.8M
Operating income -12.2M -3.9M -854.1K -138.1K
Non operating interest income
Income 48K 0
Expense 4.3M 1.6M 0
Other income expense -7.5M
Pretax income -16.5M -13.1M -854.1K -138.1K
Tax provision
Net income -16.5M -13.1M -854.1K -138.1K
Basic EPS -0.6 -0.4 0.0 0.0
Diluted EPS -0.6 -0.4 0.0 0.0
Basic average shares 29.5M 29.6M 29.6M 29.6M
Diluted average shares 29.5M 29.6M 29.6M 29.6M
EBITDA -12.2M -3.9M -854.1K -138.1K
Net income from continuing op. -16.5M -13.1M -854.1K -138.1K
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 19 minutes

03:40
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).